Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Study of Infliximab for the treatment of patients with active Ulcerative Colitis. Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or treatment with a real dr.. We aren't doctors. Always consult your mD on Study of Infliximab for the treatment of patients with active Ulcerative Colitis. conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Study of Infliximab for the treatment of patients with active Ulcerative Colitis. Clinical research trials and Study of Infliximab for the treatment of patients with active Ulcerative Colitis. medical trials occur in many of places across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectiveness of new does drugs. The role of the studies / undertakings is to figure out certain human healthcare questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to locate treatments for all forms of circumstances, including Study of Infliximab for the treatment of patients with active Ulcerative Colitis.. Study of Infliximab for the treatment of patients with active Ulcerative Colitis. Clinical Trials and other clinical trials permit volunteers to get medical treatment options before they are available to the masses. Most times the human subjects acquire treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Study of Infliximab for the treatment of patients with active Ulcerative Colitis. clinical trial. Participants oftentimes recieve the finest healthcare available for their Study of Infliximab for the treatment of patients with active Ulcerative Colitis. condition. Dangers are a reality, nonetheless, and might include extra or frequent physician calls, health hazards (potentially life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "S" Clinical Trials Conditions > Study of Infliximab for the treatment of patients with active Ulcerative Colitis.

Study of Infliximab for the treatment of patients with active Ulcerative Colitis.



Study of Infliximab for the treatment of patients with active Ulcerative Colitis.

For Condition: Ulcerative Colitis
Status: Recruiting
Sponsor(s): Centocor ,
Synopsis: A research study to evaluate the safety and effectiveness of an investigational drug is currently being conducted in adults with moderate to severe ulcerative colitis. The aim of the international study is to evaluate the efficacy and safety of Infliximab in patients with active ulcerative colitis. The study is being conducted in the US, Canada, Denmark, Spain, UK, Belgium and Germany.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients may be eligible for this study if they: - Have had ulcerative colitis of at least 3 months duration. - Have active disease - Are at least 18 years old. - Agree to use a barrier method of birth control during the study. Exclusion Criteria Patients will not be eligible for this study if they: - Have severe colitis - Are pregnant or breast-feeding. - Have used investigational drug within 30 days prior to screening. - Have received previous administration of infliximab. - Have a concomitant diagnosis of congestive heart failure (CHF).
Total Enrollment: 

Location and Contact Information:

Mayo Clinic *Recruiting*
Rochester,  Minnesota,  55905
United States
Recruiting William  Sandborn 507-284-0959

Academisch Ziekenhuis Gasthuisberg *Recruiting*
Leuven,  ,  B-3000
Belgium
Recruiting Paul  Rutgeerts


Additional Information:
Study ID Numbers:
  CO168T37; 
Study Start Date: March 2002
Record last reviewed: November 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00036439

Other Ulcerative Colitis Studies:
1. Study of Infliximab for the treatment of patients with active Ulcerative Colitis.

2. Humanized anti-IL-2 receptor monoclonal antibody in moderate-to-severe ulcerative colitis

3. Research Study in Patients With Severe Ulcerative Colitis

4. Left-Sided Ulcerative Colitis Study

5. Safety and efficacy of two diffrent doses of Asacol in the treatment of moderately active ulcerative colitis

Related Studies:

Other Ulcerative Colitis Clinical Trials
Other Clinical Trials
Other Leuven Clinical Trials

Study of Infliximab for the treatment of patients with active Ulcerative Colitis.

Modify your Search

  Other Ulcerative Colitis Clinical Trials
  Other Clinical Trials
  Other Leuven Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103